Sarepta’s Duchenne Gene Therapy Placed on Hold in Europe Pending Death Investigation

Sarepta’s Duchenne Gene Therapy Placed on Hold in Europe Pending Death Investigation

Source: 
BioSpace
snippet: 

The European Medicines Agency asked for three clinical trials to be placed on hold until the exact cause of death of a US teenager, who suffered acute liver failure after receiving Elevidys, can be precisely determined.